0001683168-24-002286.txt : 20240410
0001683168-24-002286.hdr.sgml : 20240410
20240410215135
ACCESSION NUMBER: 0001683168-24-002286
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240408
FILED AS OF DATE: 20240410
DATE AS OF CHANGE: 20240410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Downs Christopher
CENTRAL INDEX KEY: 0001705978
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39126
FILM NUMBER: 24837007
MAIL ADDRESS:
STREET 1: 31700 RESEARCH PARK DRIVE
CITY: MADISON HEIGHTS
STATE: MI
ZIP: 48071
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001729427
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 822318545
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: 1-800-946-9185
MAIL ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
4
1
ownership.xml
X0508
4
2024-04-08
0
0001729427
CNS Pharmaceuticals, Inc.
CNSP
0001705978
Downs Christopher
C/O CNS PHARMACEUTICALS, INC.
2100 WEST LOOP SOUTH, SUITE 900
HOUSTON
TX
77027
0
1
0
0
Chief Financial Officer
0
Option to purchase common stock
0.2586
2024-04-08
4
A
0
40000
A
2034-04-08
Common Stock
40000
201.572
D
Restricted Stock Units
2024-04-08
4
A
0
40000
A
Common Stock
40000
241.572
D
The options set forth in the table vest in 36 equal monthly installments over three years.
Issued in connection with the reporting person's employment with the Company.
Each restricted stock unit represents a contingent right to receive one share of Company common stock.
The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.
/s/ Christopher Downs
2024-04-10